Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIPAC-OvPac 1/2a: Paclitaxel PIPAC in Platinum-resistant Recurrent Ovarian Cancer
KCT0010597Phase 2Not yet recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in ovarian cancer, sponsored by Seoul National University Hospital. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
paclitaxel
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on KCT0010597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0010597.